Next Article in Journal
Characterization of Immune Cell Populations and Acid-Sensing Receptors in the Human Esophagus
Next Article in Special Issue
The Esophageal Microbiota in Esophageal Health and Disease
Previous Article in Journal
Irritable Bowel Syndrome: Current Landscape of Diagnostic Guidelines and Therapeutic Strategies
Previous Article in Special Issue
New Onset Inflammatory Bowel Disease Risk Following Bariatric Surgery: A Systematic Review and Meta-Analysis of Observational Studies
 
 
Review
Peer-Review Record

Pathognomonic Signs in Pancreatic Cystic Lesions: What Gastroenterologists and Involved Clinicians Need to Know

Gastroenterol. Insights 2024, 15(3), 810-818; https://doi.org/10.3390/gastroent15030057
by Alberto Martino 1, Luca Barresi 2,*, Francesco Paolo Zito 1, Michele Amata 3, Roberto Fiorentino 4, Severo Campione 5, Alessandro Iacobelli 5, Enrico Crolla 6, Roberto Di Mitri 3, Carlo Molino 6, Marco Di Serafino 7 and Giovanni Lombardi 1
Reviewer 1: Anonymous
Reviewer 2:
Gastroenterol. Insights 2024, 15(3), 810-818; https://doi.org/10.3390/gastroent15030057
Submission received: 8 August 2024 / Revised: 1 September 2024 / Accepted: 9 September 2024 / Published: 12 September 2024
(This article belongs to the Special Issue Recent Advances in the Management of Gastrointestinal Disorders)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

A review of the pathognominic signs in pancreatic cysts is important and this paper lists some of those, but not all. Needle confocal laser endomicroscopy findings  are pathognomic and should be included in a paper like this.  I am not sure of the usefulness of chylous cyst fluid for lymphangiomas. I have never obtained a TG level on cyst fluid.

The figures are great. I would consider adding a CT Abdomen to show the central scar since it is seen better on CT. 

 

Comments on the Quality of English Language

Fair. Incorrect usage of some words. For example, line 36, instead of "differential diagnosis" I would only use diagnosis. We are able to make a differential diagnosis for pancreatic cysts, but making an more precise diagnosis is difficult. Also I would use "premalignant" instead of "borderline" (line 25). I do not see a reason for Figure 3B as it is not related to fish mouth papilla. 

Line 149 "degenerated IPMN"- I do not know what that means. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Despite the not-so-tremendous level of novelty of the study, I recognize the usefulness of the material and its good preparation. Readers of this review can feel the interest and professionalism of the authors when reading this manuscript.

I want to note the multidisciplinary approach to the actual problem of pancreatic neoplasia (since this is one of the oncological diseases, the morbidity and mortality of which continues to grow in recent years).

As improvements to the manuscript, I would like to suggest the following:

- to expand the radiological-pathological comparisons, for example, microphotographs of a stellate scar or chylous cysts can be given;

- to expand the pathomorphological description of IPMN and MSN, to show the pathohistological changes behind the fish mouth/eye papilla;

- add information about calcification of the pancreas in other diseases to enrich the differential diagnosis.

I believe this manuscript is valuable to doctors from a practical point of view, so I support the possibility of publication.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

Thank you for the revisions on the paper. I believe that the information added has significantly enrched this manusceript. 

Back to TopTop